Anifrolumab OverviewAnifrolumab, sold under the brand name Saphnelo, is a monoclonal antibody used for the treatment of systemic lupus erythematosus (SLE). It binds to the type I interferon receptor, blocking the activity of type I interferons such as interferon-α and interferon-β.[medical citation needed] Anifrolumab was approved for medical use in the United States in August 2021.[5...
Read more Anifrolumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Anifrolumab
Recent Anifrolumab Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 300mg/2ml(150mg/ml)
Other drugs which contain Anifrolumab or a similar ingredient: (1 result)
- SAPHNELO Anifrolumab-fnia